Sort
53,477 grants matching “addiction”
California-Arizona Clinical Trials Network Node
$1,500,000University Of California San Francisco · U10 · FY2004 · DA
CLINICAL RESEARCH COOPERATIVE
$1,500,000University Of Pennsylvania · U10 · FY2003 · DA
ADDICTION TECHNOLOGY TRANSFER CENTER
$1,500,000National Institute On Drug Abuse · Y01 · FY2011 · DA
SBIR Phase II: Novel, injectable, long-acting, local anesthetic for postoperative pain management
$1,499,979Brett Davis · Rebel Medicine Inc · · FY2023 · TIP
ADDICTION TECHNOLOGY TRANSFER CENTER
$1,499,938National Institute On Drug Abuse · Y01 · FY2010 · DA
Clinical Phase I trials on an IND single molecule dual inhibitor of Cav3 channels and soluble epoxide hydrolase for treatment of neuropathic pain
$1,499,931Xinmin Simon Xie · Afasci, Inc. · R44 · FY2024 · NS
Clinical Phase I trials on an IND single molecule dual inhibitor of Cav3 channels and soluble epoxide hydrolase for treatment of neuropathic pain
$1,499,931Xinmin Simon Xie · Afasci, Inc. · R44 · FY2023 · NS
Emory-GSK-NIMH Collaborative Mood Disorders Initiative
$1,499,366Emory University · U19 · FY2005 · MH
New England Primate Research Center Base Grant
$1,499,216Jeffrey S Flier · Harvard Medical School · P51 · FY2009 · RR
CENTER FOR DRUG ABUSE RESEARCH
$1,499,214Virginia Commonwealth University · P50 · FY2001 · DA
NanoART Manufacture, Delivery and Pharmacokinetics for Optimizing Drug Adherence
$1,498,944Howard Eliot Gendelman · University Of Nebraska Medical Center · P01 · FY2013 · DA
HEALing Communities Study Data Coordinating Center
$1,498,866Emmanuel Aja Oga · Research Triangle Institute · UM1 · FY2022 · DA
Developmental Exposure Alcohol Research Center
$1,498,835Terrence Deak · State University Of Ny,Binghamton · P50 · FY2022 · AA
DRUG ABUSE TREATMENT EVALUATION CENTER
$1,497,192University Of Pennsylvania · P50 · FY2001 · DA
Therapeutic Opportunities for Pediatric Astrocytoma
$1,496,990Rosalind A Segal · Dana-Farber Cancer Inst · P01 · FY2013 · CA
Phase 0/1b Clinical Trial of Novel Therapeutic Agent MT-110 for the Reduction of Methamphetamine Use - Part 2
$1,496,586Erica J Young · Myosin Therapeutics Inc. · R44 · FY2025 · DA
16/24 Healthy Brain and Child Development National Consortium
$1,496,351Nathan A Fox · Univ Of Maryland, College Park · U01 · FY2023 · DA
Alcohol Associated Outcomes Among HIV+/-Aging Veterans
$1,496,218University Of Pittsburgh At Pittsburgh · R01 · FY2001 · AA
MUSC Specialized Center of Research Excellence on Sex Differences Renewal 2022
$1,495,542Aimee L McRae-Clark · Medical University Of South Carolina · U54 · FY2024 · DA
MUSC Specialized Center of Research Excellence on Sex Differences Renewal 2022
$1,495,542Aimee L McRae-Clark · Medical University Of South Carolina · U54 · FY2025 · DA
Neural Substrates of Reward Processing and Emotion
$1,494,771Elisabeth A Murray · National Institute Of Mental Health · ZIA · FY2016 · MH
NIDA CENTGER FOR GENETIC STUDIES
$1,494,730Rutgers The St Univ Of Nj New Brunswick · N01 · FY2000 · DA
Immunopharmacotherapy for Mitigating Opioid Addiction
$1,494,700Kim D Janda · Scripps Research Institute, The · UH3 · FY2018 · DA
Comparative Effectiveness of Alcohol Treatments
$1,494,669Georgiy Bobashev · Research Triangle Institute · RC4 · FY2010 · AA
Boston Alcohol Research Collaboration on HIV/AIDS - Comorbidity Center (Boston ARCH CC)
$1,494,050Michael D Stein · Boston University Medical Campus · P01 · FY2021 · AA